+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 210 Pages
  • Global
From
Multiple Myeloma Drugs Market Report 2026 - Product Thumbnail Image

Multiple Myeloma Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Keloid Treatment - Global Strategic Business Report - Product Thumbnail Image

Keloid Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 280 Pages
  • Global
From
Hirsutism Treatment - Global Strategic Business Report 2026 - Product Thumbnail Image

Hirsutism Treatment - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 375 Pages
  • Global
From
Asia Pacific Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

Asia Pacific Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 94 Pages
  • Asia Pacific
From
Darier Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Darier Disease Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 172 Pages
  • Global
From
Wart Removers - Global Strategic Business Report - Product Thumbnail Image

Wart Removers - Global Strategic Business Report

  • Report
  • November 2026
  • 278 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report 2026 - Product Thumbnail Image

Pruritus Therapeutics - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 203 Pages
  • Global
From
Myelodysplastic Syndrome Market Report 2026 - Product Thumbnail Image

Myelodysplastic Syndrome Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
ENT Devices Market Report 2026 - Product Thumbnail Image

ENT Devices Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Dermatological Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Dermatological Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 422 Pages
  • Global
From
Small Cell Lung Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Non-Small-Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Small-Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Europe Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

Europe Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 93 Pages
  • Europe
From
LAMEA Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

LAMEA Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 93 Pages
  • Africa, Middle East
From
North America Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

North America Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 83 Pages
  • North America
From
B-cell Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

B-cell Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Cancer Biomarkers - Global Strategic Business Report 2026 - Product Thumbnail Image

Cancer Biomarkers - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 474 Pages
  • Global
From
Solid Tumors Target Proteins Market - Global Forecast 2026-2032 - Product Thumbnail Image

Solid Tumors Target Proteins Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
G-Protein Coupled Receptors Market - Global Forecast 2026-2032 - Product Thumbnail Image

G-Protein Coupled Receptors Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 189 Pages
  • Global
From
Loading Indicator